BELTEST-IT Trademark

Trademark Overview


On Tuesday, December 22, 2020, a trademark application was filed for BELTEST-IT with the United States Patent and Trademark Office. The USPTO has given the BELTEST-IT trademark a serial number of 79310327. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 19, 2022. This trademark is owned by PharmACT Holding AG. The BELTEST-IT trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

In-vitro reagents for diagnostic veterinary use; in-vitro reagents for diagnostic medical use; in-vitro diagnostic preparations for medical use; immunoassay reagents for medical use; insulin; genetic identity tests comprised of reagents for medical purposes; chemical test reagents for veterinary use; medical diagnostic test strips; medical diagnostic reagents and assays for testing of body fluids; test strips for measuring blood glucose levels; reagents for use in medical genetic testing; reagents for use in diagnostic tests for medical purposes; cotton swabs for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use in veterinary genetic testing; chemical test reagents for medical use; reagents for use with analyzers for medical use; reagents for use with analyzers for veterinary purposes; reactants for veterinary diagnosis; swabs for medical use; reagents for medical use; biological indicators for medical diagnosis; indicators for medical dia...

Insulin syringes sold empty; genetic testing apparatus for medical purposes; diagnostic testing instruments for use in immunoassay procedure for medical use; testing apparatus for medical purposes, namely, genetic testing apparatus for medical purposes, DNA and RNA testing apparatus for medical purposes, medical diagnostic apparatus for testing for blood analysis, plasma analysis, serum analysis, blood component analysis, feces analysis, urine analysis, tissue analysis, tissue fliud analysis, body secretion analysis; membrane test plates for use in medical diagnostics; medical test kits for diabetes monitoring for home use; test probes for medical use; apparatus for carrying-out diagnostic tests for medical purposes, namely, ultrasound diagnostic apparatus, nuclear medical diagnostic imaging apparatus, medical apparatus for diagnostic radiopharmaceutical use, organoleptic diagnostic testing apparatus; diagnostic testing instruments for use in immunoassay procedure for medical purposes;...

General Information


Serial Number79310327
Word MarkBELTEST-IT
Filing DateTuesday, December 22, 2020
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements


Description of MarkThe mark consists of the wording "Beltest-it" in stylized blue letters with the "BEL" portion in dark blue and the rest of the letters in light blue.
Goods and ServicesIn-vitro reagents for diagnostic veterinary use; in-vitro reagents for diagnostic medical use; in-vitro diagnostic preparations for medical use; immunoassay reagents for medical use; insulin; genetic identity tests comprised of reagents for medical purposes; chemical test reagents for veterinary use; medical diagnostic test strips; medical diagnostic reagents and assays for testing of body fluids; test strips for measuring blood glucose levels; reagents for use in medical genetic testing; reagents for use in diagnostic tests for medical purposes; cotton swabs for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use in veterinary genetic testing; chemical test reagents for medical use; reagents for use with analyzers for medical use; reagents for use with analyzers for veterinary purposes; reactants for veterinary diagnosis; swabs for medical use; reagents for medical use; biological indicators for medical diagnosis; indicators for medical diagnosis, namely, biological indicators for monitoring sterilization processes for medical purposes; diagnostic chemical reagents for medical use; reactants for medical diagnosis; diagnostic preparations for medical or veterinary purposes; cotton wool in the form of sticks for medical use; chemical reagents for veterinary use; cellulose wadding for medical purposes; diagnostic substances for medical use; reagents for use in analysis for veterinary purposes; enzymes for medical purposes; reagents for analytical purposes for veterinary purposes; tampons for medical purposes; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic testing materials, namely, chemical preparations, chemical reagents, test strips, biological indicators for medical use; enzyme preparations for medical purposes; chemical preparations for testing blood for medical purposes; chemical preparations for medical purposes, namely, chemical preparations for medical and veterinary diagnostic purposes; chemical preparations for medical purposes for the treatment of treatment or prophylaxis of the nervous system, drug for treatment orprophylaxis of the endocrine system, drug for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable immune suppressive agents, injectable distinfectant agents, injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorder, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatose, heterozygous familial hypercholesterolemia, diabetic foot syndrome, arterial hypertension or cardiac insufficiency, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis ALS, cerbral insult, brain trauma, cerebral inflammations, or autoimmune encephalitis, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, enthesiopathy, insertion tendinosis, insertion tendinopathy, tendinitis, periarthritis, periathrosis, arthosis, osteoarthritis, fibrosis, renal fibrosis, liver fibrosis, cardiac fibrosis, cardiac valve fibrosis, pulmonary fibrosis, pulmonary cirrhosis, pulmonary sclerosis, cerebral insult, cerebral stroke, apoplectic insult, apoplexia cerebri, ictus apoplecticus, cerebral infarction, brain scars, gliosis, contracture, fibrotendinous contracture, fibrous contracture, joint contracture, tendon contracture, Dupuytren's contracture, Dupuytren's disease, glaucoma, eye pressure elevation, intraocular pressure elevation, primary chronic glaucoma, multiple sclerosis, disseminated demyleinating encephalomyelitis, encephalomyelitis disseminata, encephalitis disseminata, cerebral polysclerosis, amyotrophic lateral sclerosis, myatrophic lateral sclerosis, motoneuron disease, Lou Gehrig's syndrome, postcovid syndrome, longcovid syndrome; cellulose wool for medical use; reagents for analytical purposes for medical purposes; chemical reagents for medical use; enzyme preparations for veterinary purposes; reagent paper for medical or veterinary purposes; impregnated medicated wipes; medicinal preparations and substances, namely, for the treatment or prophylaxis of the nervous system, drug for treatment orprophylaxis of the endocrine system, drug for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable immune suppressive agents, injectable distinfectant agents, injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorder, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatose, heterozygous familial hypercholesterolemia, diabetic foot syndrome, arterial hypertension or cardiac insufficiency, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis ALS, cerbral insult, brain trauma, cerebral inflammations, or autoimmune encephalitis, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, enthesiopathy, insertion tendinosis, insertion tendinopathy, tendinitis, periarthritis, periathrosis, arthosis, osteoarthritis, fibrosis, renal fibrosis, liver fibrosis, cardiac fibrosis, cardiac valve fibrosis, pulmonary fibrosis, pulmonary cirrhosis, pulmonary sclerosis, cerebral insult, cerebral stroke, apoplectic insult, apoplexia cerebri, ictus apoplecticus, cerebral infarction, brain scars, gliosis, contracture, fibrotendinous contracture, fibrous contracture, joint contracture, tendon contracture, Dupuytren's contracture, Dupuytren's disease, glaucoma, eye pressure elevation, intraocular pressure elevation, primary chronic glaucoma, multiple sclerosis, disseminated demyleinating encephalomyelitis, encephalomyelitis disseminata, encephalitis disseminata, cerebral polysclerosis, amyotrophic lateral sclerosis, myatrophic lateral sclerosis, motoneuron disease, Lou Gehrig's syndrome, postcovid syndrome, longcovid syndrome; reagents for microbiological analysis for veterinary purposes; impregnated medicated swabs; diagnostic reagents for medical use; enzymes for veterinary purposes; reagents for microbiological analysis for medical purposes; reagent paper for medical purposes; reagent paper for veterinary purposes; capillary stabilizing agents for medical purposes; diagnostic agents for medical use; wadding for medical purposes; dental preparations for disclosing plaque
Indication of Colors claimedThe color(s) dark blue and light blue is/are claimed as a feature of the mark.
Goods and ServicesInsulin syringes sold empty; genetic testing apparatus for medical purposes; diagnostic testing instruments for use in immunoassay procedure for medical use; testing apparatus for medical purposes, namely, genetic testing apparatus for medical purposes, DNA and RNA testing apparatus for medical purposes, medical diagnostic apparatus for testing for blood analysis, plasma analysis, serum analysis, blood component analysis, feces analysis, urine analysis, tissue analysis, tissue fliud analysis, body secretion analysis; membrane test plates for use in medical diagnostics; medical test kits for diabetes monitoring for home use; test probes for medical use; apparatus for carrying-out diagnostic tests for medical purposes, namely, ultrasound diagnostic apparatus, nuclear medical diagnostic imaging apparatus, medical apparatus for diagnostic radiopharmaceutical use, organoleptic diagnostic testing apparatus; diagnostic testing instruments for use in immunoassay procedure for medical purposes; testing apparatus for medical purposes, namely, for immunochemical tesing, diagnostic apparatus for testing for viruses or bacteria, genetic testing apparatus, apparatus for DAN and RNA testing for medical purposes; medical apparatus and instruments, namely, medical radiation apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, electromagnetic drug delivery apparatus for medical use, medical instruments for cutting tissues, medical instruments for examing women's reproductive organs, medical instruments for use in general surgery, medical instruments for use in performing biopsies; medical apparatus for testing the level of glucose in the blood; chromatographic apparatus for medical purposes; medical diagnostic apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; measuring devices for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices measuring tumors; chromatographic devices for medical purposes; measuring instruments adapted for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices measuring tumors; tongue depressors for medical purposes; apparatus for analysing substances, namely, body fluids, blood, body tissues, bacterial cultures, mucous for medical use; medical therapy instruments, namely, implantable radiation therapy devices consisting of radioactive seeds, medical devices for moxibustion therapy, a device for improving cardiac performance through aortic flow therapy; blood collection tubes for medical use; chromatographic columns for medical use; medical diagnostic saliva vials; blood group analyzers for medical use; fibrescopes for medical use; chromatogram analyzers for medical use; medical analytical apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; automated analyzers for foreign matter contained in body fluids for medical use; chromatographic instruments for medical use; medical apparatus for diagnosing suspected heart attacks; diagnostic measuring apparatus for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices meauring tumors; diagnostic apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; apparatus for DNA and RNA testing for medical purposes; electronic apparatus for medical purposes, namely, electronic medical appliances for wound healing, electronic temperature monitors, electronic muscle stimulators, EKG machines, medical apparatus for monitoring vital signs, blood property and respiratory events; chromatography plates for medical use; chromatographic instruments for medical purposes; body composition analyzers for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmACT Holding AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressDE

Party NamePharmACT Holding AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressDE

Trademark Events


Event DateEvent Description
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 13, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 14, 2022ASSIGNED TO LIE
Friday, March 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 1, 2021REFUSAL PROCESSED BY IB
Wednesday, July 14, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, July 14, 2021REFUSAL PROCESSED BY MPU
Tuesday, July 13, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 12, 2021NON-FINAL ACTION WRITTEN
Wednesday, July 7, 2021ASSIGNED TO EXAMINER
Monday, June 28, 2021ASSIGNED TO EXAMINER
Friday, June 18, 2021ASSIGNED TO EXAMINER
Tuesday, May 18, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, May 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 8, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB